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INTRODUCTION
Although one of the main goals in ophthalmology is to preserve user and 
maintain the integrity of the eye, it may become necessary to remove the globe 
in a number of clinical settings. These circumstances includes selected ocular 
tumors, a globe that has sustained serious trauma and is damaged beyond repair, 
an eye that is blind from endophthalmitis, a blind and painful eye, or at times a 
globe  that  is  deformed  and  not  amenable  to  ocular  prosthesis  because  of 
discomfort1, restoration of both comfort and cosmesis are extremely important 
to the patient who is eager to resume social and occupational functions.
The psychological trauma to the patient from the loss of an eye can be 
much worse than the physical disability.  This is more evident in instance of 
sudden loss of the globe secondary to trauma or an unsuspected malignancy. 
Losing an organ that once provided sights depth of perception, peripheral vision 
colour vision,  job opportunities  a livelihood,  personal self  esteem and other 
necessities  is  approached  with  a  sense  of  fear,  self  consciousness  and 
apprehension2. Because of the degree of psychological trauma, almost no other 
common surgery in ophthalmology requires as much comparison on the part of 
the ophthalmologist as discussing the preparation for surgery and the patients 
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post  operative  appearance  and  problem,  providing  emotional  assistance  in 
returning the patient to a productive life3.  
Enucleation / Evisceration of non-seeing disfigured or painful eye leaves 
the  patient  with  an  empty  or  anophthalmic  socket  resulting  in  a  volume 
depletion  of  7-7.5cm3 from  the  total  orbital  volume  of  30  cm3.  In  1885, 
Dr.P.H.Mules4, first introduced hollow spherical glass to fill this lost volume 
for  cosmetic  restoration.  The  common  problem  arising  from  anophthalmic 
sokets  have been summarized by Tyers  & Collins5 described in  the  clinical 
entity of post enucleation socket syndrome. The distinctive clinical features of 
ptosis / retraction of upper eyelid / of deep superior sulcus, lower lid laxity and 
enophthalmos  in  1983,  though  the  exact  aetiopathogenesis  ware  better 
understand when Smith et al6 employed CT scan to study anophthalmic sockets.
Orbital implants are used as fillers following enucleation or evisceration 
surgeries  to  replace  the  lost  volume.  The  complications  that  followed  and 
occurred in the early implant surgeries have given rise to the usage of a variety  
of materials in the following years.
      The  removal  of  an  eye  and  the  management  of  anophthalmic  socket 
remains a challenge for the ophthalmologist and ocularist. Excellent cosmetic 
results  and  long  term  control  of  socket  problems  are  difficult  to  achieve 
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consistently and the procedure can be emotionally unsatisfactory for the patient 
and the surgeon. The goal of each of the various procedure is a natural post 
operative appearance with symmetry, excellent motility and no socket irritation 
and discharge and the maintenance of maximal anatomic integrity of the orbit. 
No  single   procedure  answers  all  these  requirements  as  evidenced  by  the 
various  congeal  techniques  advocated  over  the  year7.  This  study  aims  at 
analyzing the outcomes following the use of silicone ball  implants.
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ENUCLEATION & EVISCERATION:
Enucleation:
Indications for enucleation
It can be classified as absolute and relative indications.
 Absolute indications are
1. Intraocular  malignancy.  E.g.  Retinoblastoma,  malignant  melanoma, 
metastatic tumours.
2. Sympathetic ophthalmia
3. Extensively traumatized globe
Relative indications are
1. Painful blind eye of unknown etiology
2. Phthisis bulbi
3. Deformed cosmetically unacceptable globe. e.g. Staphyloma.
Techniques:
There are 6 main types of primary enucleation procedure.
1. The simplest  procedure  is  an  enucleation  without  the  insertion  of  an 
implant. This results in a less satisfactory cosmesis.
2. The second type of enucleation procedure is the placement of an exposed 
integrated implant. This resulted in good motility but the complication 
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rate  such  as  extrusion,  infection  were  high.  This  procedure  is  not 
followed nowerdays.   
3. The third procedure, the implant is inserted within Tenon’s capsule with 
or without the attachment of the recti muscles anterior to the implant or 
to  the  implant  itself.  Implants  are  also  inserted  posterior  to  posterior 
layer of Tenon’s capsule within the fatly tissue of the muscle cone.
4. The  fourth  type  includes  the  placement  of  a  wrapped  implant  with 
several fascia lata grafts or synthetic material surrounding the implant. 
The extraocular muscles can be attached directly to the wrapped implant.
5. The fifth procedure incorporates dermis fat grafts.    
6. At present, the placement of a wrapped hydroxy apatite or polyethylene 
implant in  the state  of  the  art  in  implant materials  but  the long term 
results & complication rate of this procure is unknown.                          
Advantages of enucleation:
1. The histologic architecture in preserved.
2. The livelihood of cutting through an undiagnosed intraocular tumor is 
reduced.
3. All the uveal tissue in removed thereby lowering the risk of sympathetic 
ophthalmia.8,9,10
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Evisceration:
Evisceration is indicated in
1. Endophthalmitis indicated painful blind eye.
2. Painful / painless or disfigured eye due to absolute glaucoma, uveitis, 
corneal scarring etc.
3. Globe injured by trauma but with an intact scleral shell in which there is 
no threat of sympathetic ophthalmia.
Advantages of Evisceration:
1. The  meninges  and  optic  nerve  are  not  related  thereby  reducing  the 
chance of bacterial seeding of the subarachnoid space & development of 
meningitis.
2. Drainage  of  the  ocular  abscess  is  performed  quickly  and  early  with 
excellent operative exposure and superb  visualisation.
3. Excessive bleeding from the inflamed orbital soft tissue is avoided.
4. Sclera  remains  intact  &  serves  as  a  barrier  the  progression  of  the 
suppurative process. (although seeding can occur through the emissary & 
vortex vein)
5. Delicate orbital anatomic structure  are not disturbed.
6. Normal orbital physiology and full ocular mobility are anticipated once 
the infection clears.
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7. Globe remains fixed in position by Tenon’s capsule, extraocular muscles 
and the intermuscular septum.
These factors tend to enhance the post operative cosmesis & reduce the 
burden  of long term complications of evisceration compared with enucleation. 
Disadvantages of Evisceration:
1. It  is  theoretically  impossible  to  remove  all  the  uveal  tissue  from the 
scleral coat so there exists a potential risk of sympathetic ophthalmia .
2.  Unsuspected  intra  ocular  malignancy  can  be  disseminated  by 
manipulation of intra ocular contents.
3. Pathologic evaluation of globe is often incomplete & not satisfactory.
Contraindications:
1. Existence or possibility of an intra ocular tumor.
2. Phthisis bulbi with marked shrinking of the globe.
3. Advanced degeneration of the globe.
4. When pathologic investigation of ocular contents is desired.
5. Patients  who  have  nystagmus  may  develop  bizarre  movement  with 
prosthesis 
6. Past  or  present  history  of  systemic  malignancy  with  or  without 
detectable intra ocular tumor.
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Techniques:
The procedure  may be performed under  local  or  general  anaesthesia. 
Even  under  general  anaesthesia,  retro  bulbar  injection  of  lignocaine  helps 
reduce bleeding & extend post operation analgesia. 
Two techniques are followed:-
1. Evisceration with retention of the cornea
2. Evisceration with keratectomy8,9,10
CHARACTERISTICS OF AN ANOPHTHALMIC SOCKET:
The characteristics of the ideal socket and eyelid on the anophthalmic 
side are:-
1. Centrally placed, well covered buried motility implant of adequate size, 
fabricated from an inert material.
2. Deep fornices.
3. Inferior lid & cul-de-sae that can support the weight and presence of the 
prosthesis.
4. Superior lid and supratarsal fold that simulates the normal follow eyelid.
5. An anophthalmic socket that is on the same place as that of the normal 
side
6. Normal position of the eyelashes.
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Changes occurring in the anophthalmic socket:
Irrespective  of  the  surgical  technique  or  modifications  used  both  in 
enucleation and evisceration surgery, certain changes occur in all anophthalmic 
sockets. These changes are somewhat less in the post-evisceration state because 
there is less disturbance of extraocular anatomic structures.
A  change  in  the  metabolism  and  circulatory  dynamics  of  the 
anophthalmic orbit occurs because a globe with its normal blood supply and 
metabolic function is no longer present. Thermography studies performed on 
anophthalmic patients showed colder readings on the anophthalmic side when 
compared to the normal size. Atrophy of orbital fat is most likely due to the 
decreased  circulation  and  decreased  metabolic  requirements  of  the 
anophthalmic socket.
There is always some atrophy of orbital fat that is most noticeable in the 
superior eyelid area where many post-enucleation patients actually develop a 
deep  sulcus  that,  when  compared  with  the  normal  side,  accentuates  an 
enophthalmic  anophthalmic  appearance.  Atrophy  of  orbital  fat  within  and 
outside the muscle cone area also contributes to the amount of enophthalmos 
present.  In  an  enucleated  orbit,  the  relationships  and support  of  the  levator 
muscle are disturbed. Although Koornneef has shown that orbital structures are 
supported by septa, displacement and sagging occurs and some degree of ptosis 
is usually present.11
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The  lower  eyelid  theoretically  is  not  affected  by  the  surgery  of  the 
anophthalmic socket – however,  in reality it  is. The lower eyelid is a major 
structural  support  of  the  prosthesis,  and  with  the  passage  of  time  and  the 
constant  weight  of  the  prosthesis,  some  sagging  inevitably  occurs.  For  this 
reason, it is very important to have as light a  prosthesis as possible.
Motility  of  the  prosthesis  in  the  anophthalmic  socket  dependents 
primarily  on the movement and depth of the fornices assisted by movement 
transmitted to the prosthesis by the posterior wall of the socket. The fornices are 
most important and account for the major range of motion of the prosthesis. On 
looking laterally, the lateral fornix should deepen such that the lateral prosthesis 
edge  falls  into  the  cavity.  At  the  same time,  the  medical  becomes  shallow 
pushing that edge laterally. A similar situation occurs when the individual looks 
in the opposite direction or up or down. The movement of a prosthesis whose 
back surface is molded to the irregularities of the posterior surface of the socket 
is further enhanced by the mechanical push of this socket surface against the 
posterior wall of the prosthesis as the patient looks in different directions.
Congenitally  anophthalmic  sockets  are  always  associated  with  some 
deficiency of midfacial and bony orbital development. In this condition, also, 
expansion by progressively larger conformers and prostheses is the procedure 
of  choice,  and  early  reconstructive  surgery  is  contraindicated.  In  congenital 
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anophthalmos, a microphthalmic eye pr remnant of the optical vesicle is usually 
present. Surgical removal is not advised.
After  the  child  has  achieved  maximum  orbital  growth  and  socket 
development  by  expansion,  then  surgical  procedures  to  further  expand  or 
modify the socket cavity in order to maintain a prosthesis can be attempted. 
Theses  include  mucous  membrane  grafting  and/or  split-thickness  grafting, 
reconstruction  of  the  eyelid  with  ear  cartilage  and/or  sclera  to  correct  an 
entropion  that  so  often  develops,  and  even  osteotomies  with  bone 
rearrangement.
The problems associated with the  congential  anophthalmic socket  are 
less easy to solve than those associated with an anophthalmic socket secondary 
to adult enucleation. The problems associated with socket development after 
enucleation during childhood fall between the above two extremes.12
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ORBITAL IMPLANTS
           The qualities of an ideal implant are, that it should some the normal 
globe  as  closely  as  possible.  The  implant  must  replace  sufficient  orbital 
volume but allow for a prosthesis of adequate anterior chamber depth, have 
minimal  rates  of  exposure  extrusion,  infection  or  inflammation  ,be  non 
antigenic & biologically inert while providing socket motility transmitted to 
the prosthesis to simulate normal globe & socket as much as possible. 
The  implant  should  be  completely  buried  and  simple  in  construction 
without     projecting and angulated surfaces that might erode the conjunctiva.
          The implant should be light weight, centred within the muscle cone, 
anchored to orbital tissue to minimize extrusion & migration and be able to be 
integrated into the extraocular muscles and orbital soft tissues without creating 
fibrous adhesions of the orbital connective tissues. It should be able to transfer 
its motility to the prosthesis. 
Replacing  the lost volume:
            Volume loss appears to be the major determinant of post-enucleation 
anatomic changes, Human  radiographic studies have confirmed that placement 
of a spherical implant within Tenon’s capsule counteracts the post-enucleation 
rotation of intraorbital contents (and associated back-tilt of the prosthesis). This 
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is true even when the implant is placed late after enucleation. Partial volume 
replacement permits  a thinner prosthesis,  thus relieving weight on the lower 
eyelid  and  minimizing  associated  ectropion  formation.  Traditionally, 
enucleation is thought to produce about a 7.0-ml loss of orbital volume, based 
on an average axial length of 24 mm. More recent studies suggest the average 
volume loss is higher, about 7.5--8.0 ml, emphasizing that there is substantial 
variability (5.5--9.0 ml). Clearly a myope with an axial length of 28 mm will 
have a greater loss of volume from enucleation than a hyperope with an axial 
length of 20 mm. Thus measuring the diameteror water displacement of the 
enucleated globe may be the most appropriate method of  determining implant 
size.  In  cases  of  phthisis  and  in  the  absence  of  a  history  of  significant 
anisometropia, an A-scan of the contralateral eye may be useful for  implant 
size selection, assuming symmetric bony orbital development and the absence 
of prior socket contracture.
          A 20-mm spherical implant has a volume of 4.2 ml  The remaining 
volume (about  3--4  ml)   must  be  replaced by the  prosthesis.  However,  the 
physical dimensions of the palpebral fissure and conjunctival cul-de-sac, plus 
problems associated with lower lid laxity produced by a heavy prosthesis, limit 
the practical maximum size and volume of the  prosthesis. Average prosthesis 
volume is about 2.0-- 2.5 ml. A recent study suggested that the upper limit of 
prosthetic  volume  is  about  4.2  ml  (in  the  presence  of  a  small  implant). 
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Interestingly,  among patients  with  implant  sizes  of  14--22 mm and optimal 
prosthetic  as  judged  by  an  ocularist,  the  average  prosthesis  volumes  were 
remarkably similar: 2.2--2.3 ml. Thus when a small implant is used, the overall 
volume  deficit  (orbital  volume  loss  from  enucleation  implant  þ  prosthetic 
volume]) may be even greater. Placing an implant larger than 22  mm may carry 
higher exposure rate in the early postoperative period as Tenon’s capsule must 
be closed with greater tension. At the extreme end, a large implant (usually 24 
mm) will prevent the ocularist from fitting an artificial eye with enough antero-
posterior depth (4 mm) to create a realistic anterior chamber depth. In addition, 
crowding of the conjunctival fornices could restrict  prosthesis movement. In 
attempt to place larger implants in the enucleated orbit without placing undue 
tension on Tenon’s capsule, placement of the implant posterior to the posterior 
layer of Tenon’s capsule has been advocated; however, practice this may be 
difficult secondary to tissue edema and access to the deep orbit.13
HISTORICAL PERSPECTIVE OF ORBITAL IMPLANTS:
Removal  of  an  eye  for  treatment  of  severe  ocular  disease  was  first 
described by George Bartisch more than 400 years ago14. A hook was passed 
through the globe followed by sharp dissection to  sever  the  globe from the 
orbit.  The  procedure  was  performed  without  an  anesthetic  and  considered 
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“dreadful” even by standards of that era.15 The resulting socket deformity was 
not suitable for fitting with an ocular prosthesis.
It  was  not  until  1841  that  the  foundation  for  current  enucleation 
techniques was established in separate reports by O’Ferrall Ana Bonnet. It was 
more than 40 years later before orbital implants were introduced into modern 
anophthalmic  surgery.16 P.H.Mules  placed  a  glass  spherical  implant  (the 
“Mules” sphere) into an eviscerated socket in 1885, and W.A.Frost, 1 year later, 
introduced  a  similar  implant  into  Tenon’s  capsule  after  an  enucleation 
procedure.4 The  Mules  sphere  revolutionized  anophthalmic  socket 
reconstructive  surgery  by  replacing  lost  orbital  volume  and  diminishing 
postoperative  socket  retraction.  Whereas  improved  techniques  reduced 
problems  with  these  implants,  complications  including  migration,  extrusion, 
and a tendency to shatter with sudden temperature changes led to a search for 
improved implant materials.17 Celluloid, sponge, peat moss, agar, petrolatum, 
rubber, paraffin, ivory, wool, cork, silk, cartilage, fat, fascia lata, bone, animal 
eyes,  and cat  gut  were among the  organic  materials  suggested for  use after 
enucleation.18 Vitallium,  platinum,  aluminum,  silver,  gold,  and  wire  were 
inorganic substances tried as orbital implants.19 By 1941, popular implants, in 
order of preference, included: carbonized bone balls, ivory, decalcified bone, 
formalized cartilage, and the Mules glass sphere.20 Before this time, all implants 
were completely buried.
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In 1941, Ruedemann introduced a combined implant with a posteriorly 
oriented tantalum mesh and with an anteriorly exposed acrylic prosthetic eye21. 
The posterior portion of the implant – prosthesis  was attached to  the rectus 
muscles, and motility and cosmesis were greatly improved over buried implants 
used before 1941. Shortcomings including a high rate of infections limited the 
acceptance of Ruedemann’s combined implant.  Numerous partially  exposed, 
integrated implants with direct attachment to an overlying prosthesis to improve 
motility were subsequently developed by Culter, Guyton, Whitney, Rolf, Stone, 
and others22. Use of these implants was also hindered by their high incidence of 
infection and extrusion.
By the 1950s, completely buried implant were again the focus of orbital 
surgeons. A variety of implant designs were tried with an attempt to indirectly 
couple  the  buried  implant  to  an  overlying  artificial  eye  by  modifying  the 
anterior surface of the implant as well as the posterior surface of the prosthesis. 
The  Allen23 and  subsequently  the Iowa24,25  polymethylmethacrylate  (PMMA) 
implants  were  the  culmination  of  these  investigations  into  quasi-integrated 
implants. The Iowa implant used prominent mounds, which were coupled to 
concavities on the posterior surface of the prosthesis. These mounds were later 
reduced in size to create the Universal implant, which remains in use by some 
North American ophthalmologists26,27.
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Despite  the  initial  acceptance  of  buried,  quasi-integrated  implants, 
implantation, fitting, and exposure problems continued to plague these designs. 
Ophthalmologists  turned  to  simpler  buried  implants  with  fewer  problems. 
Although other implant designs continued to surface (Uribe, Iliff and Soll-mid-
1960s), they had a limited degree of success.15,17 Little change occurred over the 
next 20 years with respect to implant design, and by 1989, spherical implants 
made  of  silicone,  glass,  or  PMMA  were  the  implants  most  widely  by 
ophthalmic plastic  surgeons.28 Spheres on their  own or wrapped in sclera or 
fascia were the implants of choice in more than 80% of primary enucleations, 
followed  by  dermis  fat  grafts  and  the  Iowa/  universal-type  quasi-integrated 
implant.28  
TYPES OF IMPLANTS:
The various implants can be divided in to 3 groups.
1. Nonintegrated implants
2. Integrated implants
3. Quasi integrated implants
1. Nonintegrated Implants:
Nonintegrated implants contain no unique apparatus for attachments to 
the extraocular muscles and do not allow in growth of organic tissue into their 
inorganic  substance.  Such implants  have  no  direct  attachment  to  the  ocular 
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prosthesis.  Materials  used  as  nonintegrated  implants  include  glass,  rubber, 
silicone,  steel,  gold,  silver,  acrylic,  and  polymethylmethacrylate  (PMMA).29 
Compared to no implant these devices provide both volume replacement and 
improved cosmesis.
Imbrication of the rectus muscles in front of a spherical implant imparts 
motility to the implant and prosthesis. Like a ball-and-socket joint, when the 
implant moves, the prosthesis moves. Because the ball and socket are separated 
by layers of Tenon’s fascia, imbricated muscles, and conjunctiva, non-pegged 
implants  offer  less  motility  than  pegged  implants.  Allen  has  suggested  and 
Beard agreed that imbrication of the recti over nonintegrated implants can result 
in  implant  migration  caused  by  contraction  of  the  rectus  muscles.29,30 Few 
studies have proved that there is no significant differences in motility offered by 
integrated & non-integrated implants. 
2. Integrated Implants:
a. Hydroxyapatite:
The hydroxyapatite orbital implant is commonly used during enucleation 
surgery.31,32 It is formed from a salt of calcium phosphate that is present in the 
mineralized portion of human bone. It is reported to be nontoxic, nonallergenic, 
and biocompatible.33  Its porous structure allows integation of fiberovascular 
tissues  into  the  stroma  of  the  implant.34 The  pore  orientation  in  the 
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hydroxyapatite sphere may influence the degree of vascularization and the poor 
vascularization might result in implant extrusion.35 Two common types of the 
hydroxyapatite  implant  are  the  Bio-Eye  hydroxyapatite  implant  (Integrated 
Orbital  Implants,  Inc.,  San  Diego,  CA)  and  the  M-Sphere  cancellous  bone 
implant (IOP, Inc., Costa, Mesa, CA).
Fibrovascular  ingrowth and density  changes  have been assessed by a 
variety or radiographic techniques, but contrast-enhanced magnetic resonance 
imaging with surface coil appears to be the modality of choice.36,37,38
b. Porous Polyethylene:
Porous  polyethylene  is  another  integrated  implant  material.  This 
spherical implant was approved by the Food and Drug Administration for use in 
reconstructive  surgery  in  1985.  Like  hydroxyapatite,  porous  polyethylene 
allows  fibrovasclar  ingrowth,  albeit  not  as  quickly  as  hydroxyapatite34,39. 
Histopathologic evaluation revealed that the fibrovascular ingrowth extended to 
the central core of the implant. Advantages of the porous polyethylene device 
are that it does not require donor sclera or other type of wrapping material, its 
cost is low in comparison to hydroxyapatite, and the extraocular muscles may 
be sutured directly to the implant. Porous polyethylene implants are smooth and 
malleable, which makes implantation easier.40,41 The device can be implanted in 
the standard fashion followed by attachment if the extraocular muscles at points 
approximating the spiral of Tillaux.41
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3. Quasi-integrated Implants:
A quasi integrated implant are the Universal or MEDPOR Quad-motility 
implant.  The mounded surface of  the  Universal  or  MEDPOR Quad-motility 
implant offers  improved motility  over  a standard sphere  and is  an excellent 
choice  if  improved  motility  is  desired.  This  implant,  however,  may  be 
somewhat difficult to put in by surgeons not familiar with their use and/or only 
using them occasionally. 42 
WRAPPING MATERIALS:
Volume augmentation as well as improved motility, decreased rates of 
extrusion, and an extra barrier to the environment have been attributed to the 
use of implant wrapping materials.43
1. Donor Sclera:
Donor sclera is the most popular wrapping material. Perry recommends 
using fresh frozen donor sclera.44 After thawing, the appropriate cultures of the 
donor sclera can be taken. The sclera is trimmed and wrapped to fit the implant, 
with  the  use  of  4-0  or  5-0  nonabsorbable  suture.  Although  donor  sclera  is 
readily available, it is expensive and the theoretical risk of transmissible disease 
exists, including prion disease, which cannot be screened for at this time. No 
case of human immunodeficiency virus transmission as a result of implanting 
donor sclera has ever been documented.45
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2. Autologous Tissue:
Autologous materials for wrapping implants include temporalis fascia, 
fascia lata, dermis, pericardium, auricular muscle complex,46 and pericranium.47 
The advantages of these materials in enucleation surgery are that autologous 
tissues are a living graft, will not elicit a foreign body response, and vascularize 
rapidly.
Drawbacks  to  autologous  tissue  grafts  are  that  harvesting  the  graft 
requires additional surgical time.45,48  Fascia lata is typically taken from above 
the  lateral  knee,  leaving  noticeable  scars  and  occasional  muscle  belly 
herniations.48 Autologous tissue remains a good alternative to banked sclera in 
selected patients.
3. Synthetic Mesh:
Vicryl (polyglactin 910) is a synthetic knitted mesh that is identical to 
the material found in Vicryl absorbable suture. Jordan et al reported success 
with Vicryl mesh, nothing its ease of insertion and attachment of extraocular 
muscles.49 An advantage of synthetic mesh is that is eliminates the possibility of 
disease transmission.
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IMPLANT SIZE:
No randomized clinical trials have been used to compare the size and 
type of implants.50  Further complicating this analysis was the fact  that  some 
used donor sclera wrapped implants,  while others used autogenous tissues.32 
Clearly, wrapping increases implant size.
Predicting  the  correct  implant  size  needed  for  adequate  volume 
replacement can also be tricky and is most often decided in the operating room. 
Kaltreider  and  coworkers  have  proposed  a  method  in  which  axial  length 
measurements of the fellow eye are used to select implant size.51   
Research  by  Kaltreider  et  al  suggested  the  use  of  A-Scan 
ultrasonography of the fellow healthy eye to provide a tool for correct orbital 
implant  size  to  replace 80% of the  volume removed at  enucleation.  Further 
studies have been that the ocular process should not be depended on to increase 
orbital volume but instead the focus should be on the placement of appropriate 
sized orbital implant. Recently an algorithm has been developed for use with 
the  above  mentioned  preoperative  method  of  assessing  the  optimal  orbital 
implant size through the use of pre-operative A-Scan ultrasonography of the 
fellow health eye. This method allows space in the anterior socket for an ocular 
prosthetic volume of 2ml when the orbital implant is placed posteriorly in the 
intra conal space.
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Globe Size (Axial Length – AL) Enucleation Evisceration
< 24 mm (hyperopes) AL -3 AL-4
> 24mm (emmetropes & myopes) AL-2 AL-3
Children AL-2 AL-3
A  scleral  wrap  adds  approximately  1.5  mm  to  the  diameter  of  the 
implant.
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SURGICAL TECHNIQUES
Enucleation with orbital implant: 
Short  and  long  term  complications  of  enucleation  surgery  are  best 
prevented  by  meticulous  initial  surgical  technique.  The  surgery  may  be 
performed by either inserting the intra-orbital implant within Tenon’s capsule 
or posterior to the posterior layer of Tenon’s capsule within the fatty tissue of 
the muscle cone.
Insertion of an intra-orbital implant within Tenon’s capsule. 
        When an implant is inserted within Tenon’s capsule, the posterior rent in 
Tenon’s capsule is closed with a 4-0 absorbable synthetic or chromic suture. 
The implant is inserted and the anterior portion of Tenon’s capsule separated 
from  overlying  conjunctiva.  The  dissection  of  anterior  Tenon’s  from 
conjunctiva is extensive in order to obtain good depth to all of the fornices. 
Particular  care,  however,  should be taken when dissecting superiorly.  In  all 
techniques, a 4-0 silk superior fornix mattress traction suture should be place 
before the superior separation of conjunctiva and Tenon’s. This helps to pull the 
levator  complex  out  of  the  way  and  avoid  injury  to  it.  Deep  fornices  are 
essential for good motility after surgery, irrespective of the technique.
29
Insertion  of  an  intraorbital  implant  posterior  to  the  posterior  layer  of 
Tenon’s capsule 
Tenon’s capsule may be divided into an anterior layer and a posterior 
layer, anterior Tenon’s capsule is defined as that portion in front of the exits of 
the  four  extraocular  rectus  muscles  and  posterior  Tenon’s  as  that  portion 
posterior to these exits.
Positioning of the intraorbital implant posterior to the posterior layer of 
Tenon’s capsule within the fatty tissue of the muscle cone, gives better cosmetic 
and functional results and also minimizes the risk of later complications such as 
migration and extrusion. This technique also allows for the more comfortable 
and safer use of a larger implant than would be possible if the implant were 
inserted within Tenon’s. 
Evisceration with orbital implant:
      The Procedure may be performed under local or general anaesthesia. Two 
techniques are followed.
1. Evisceration with retention of the cornea
2. Evisceration with keratectomy   
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CONFORMERS:
It is necessary to choose a conformer that occupies the fornices. It should 
not be so small that it falls out or so large that it places tension on the wound. 
Patel  and  coworkers  devised  a  standardized  set  of  conformers  and 
symblepharon rings that allow the surgeon to find the ideal fit.52 
Conformers can be left in for 4 to 6 weeks, at which time the patient is  
ready for prosthetic fitting.52 This is because the temporary prosthesis functions 
as  a  conformer  and  fast  cosmetic  rehabilitation  improves  the  patients’ 
psychological well-being.
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COMPLICATIONS
The complications of these surgeries can be classified as follows: 
A. Intraoperative Complications
B. Postoperative Complications 
A. Intraoperative Complications:-  
1. Removal of the Wrong Eye53
2. Loss of Extraocular Muscles
3. Orbital Hemorrhage  
4. Injury to the conjuctiva ,Tenon’s capsules
B. Postoperative Complications:- 
1. Early complications:
a. Orbital Hemorrhage and Edema
b. Orbital Infection
c. Conformer Extrusion
2. Late Complications:
a. Lax Socket
b. Enophthalmos
c. Superior Sulcus Deformity
d. Socket Contracture
e. Implant Exposure and Extrusion
f. Wound Dehiscence
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A. Intraoperative Complications
1. Loss of Extraocular Muscles:
During enucleation surgery, a rectus muscle may be lost and retract into 
the  orbit.  The likelihood of  this  can  be minimized by careful  placement  of 
traction sutures. In the event that the muscle is lost, it should be searched for 
among the soft tissues of the orbit.54 Tenon’s fascia can be grasped with forceps 
in the meridian of the muscle (in a “hand-over-hand” fashion), and the muscle 
can often be found within this tissue. The search for a lost muscle may require 
temporary removal of the implant.
2. Orbital Hemorrhage:
Before  enucleation,  patients  should  be  asked  if  they  are  taking 
anticoagulants.  If  so,  it  is  reasonable  to  discontinue  them  during  the 
preoperative period, if the physician who prescribed this medication agrees.55 
During surgery, careful dissection and handling of the soft tissues can reduce 
the  chance  of  intra-operative  orbital  hemorrhage.  Retrobulbar  infusion  of 
anesthetic with epinephrine also decreases intraoperative bleeding.
Most commonly, if hemorrhage occurs, it is controlled by packing the 
muscle cone with gauze and applying pressure. If there are identifiable bleeding 
vessels, cautery may be useful.56 
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B. Postoperative Complications
1. Early Complications: 
a. Orbital Hemorrhage and Edema:
Orbital hemorrhage after enucleation is rare and that, when it occurs, it  
should be treated with compressive bandages.57 When severe hematomas occur, 
exploration  may  be  required,  and  separate  incisions  may  minimize  wound 
dehiscence and fat atrophy. Ecchymosis of the orbit after enucleation is both 
common and temporary.54,58
b. Orbital Infection:
Orbital infection is a rare complication of enucleation, but it can lead to 
wound dehiscence.55,59 It can be characterized by chemosis and persistent pain. 
Meticulous  handling  of  tissues  and clean  surgical  technique  combined  with 
systemic and topical  antibiotics for  at  least  5 to 7 days postoperatively will  
minimize the possibility of infection.56 Infection may require removal of the 
implant,  local  and  systemic  antibiotics,  and  then  implant  replacement.54,59 
Orbital infections may be more common with integrated orbital implants.
c. Conformer Extrusion:
Conformers  may  dislodge  postoperatively,  leading  to  conjunctival 
prolapse with eventual scarring and shortening of the fornices. The patient must 
be counseled that when the conformer is removed for cleaning, it needs to be 
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replaced into its original position. In the event of conjunctival prolapse, cold 
compresses and pressure patching may be indicated.60
2. Late Complications
a. Lax Socket:
The lax socket results from the secondary effects of time, gravity, and 
the prosthesis in an anophthalmic, volume-deficient orbit combining to stretch 
the  soft  tissues  of  the  orbit.  It  is  the  most  common  late  complication  of 
enucleation, and it results in downward and anterior migration of the implant. 
This  implant  migration  causes  enophthalmos  and  deepening  of  the  superior 
sulcus with superior lid ptosis. To compensate, the patient is often fitted with a 
larger  and  heavier  prosthesis,  which  temporarily  eases  the  problem  but 
eventually results in greater downward migration, increased deepening of the 
superior sulcus, and lower lid laxity.61,62
b. Enophththalmos:
Enophthalmos results from a loss of volume after removal of the globe.63 
Attempts at correction have been aimed at restoration of orbital volume. Rose 
and  colleagues  proposed  that  restoration  of  volume  in  the  volume-deficient 
orbit be achieved sequentially, first by the use of either a dermis fat graft or 
implant and then by implantation of a silastic block into the extraperiorbital 
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space.61 Using  this  approach,  they  achieved  a  significant  reduction  in 
enophthalmos and superior lid sulcus deformities.61
c. Superior Sulcus Deformity:
A superior sulcus deformity, which is caused by loss of orbital volume 
and relaxation of tissues within the orbit,64 manifests as a deep groove or space 
between  the  upper  eyelid  and  orbital  rim,  giving  the  appearance  of 
enophthalmos  and  ptosis.60  superior  sulcus  deformity  can  be  corrected  by 
various   procedures  like  introducing  a  moldable  methylmethacrylate 
subperiosteal implant65, suturing the levator complex tendon to the periosteum 
of the superior orbital rim66, using dermis fat graft67.
d. Socket Contracture:   
Socket  contracture  comprises  a  spectrum  of  disorders  ranging  from 
shortening  of  posterior  lamella  of  the  lids  to  complete  obliteration  of  the 
fornices  with  inability  to  retain  a  prosthesis.60 Dortzbach  and  Callahan 
identified two types  of  socket  contracture  that  are  not  amenable  to  surgical 
repair:  1) Sockets  that  have significant distortion of the lid margins,  and 2) 
sockets  that  have undergone multiple  repairs.  The basic  principles  of  repair 
involve correction of any volume deficit,  replacement of mucosal tissue, and 
eradication  of  any  underlying  infection.  Attention  then  is  directed  toward 
correction of any lid abnormalities and placement of an implant, if needed. 
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Contracted Socket Grading & Management 
Grade 1 - Shelved inferior fornix.
Management- Fornix deepening suture. 
Grade 2 - Absent inferior fornix .
Management- Fornix deepening suture and mucous  membrane graft. 
Grade  3 -  Grade  2  with  absent  superior,  lateral  and  medial  fornices  with 
rounded canthi.
Management- Fornix deepening suture and dermis fat graft.
Grade 4 - Grade 3 with shrunken conjunctiva and lids.
Management- Fornix deepening suture and dermis fat graft with mucous 
membrane graft and  lid surgery .
Grade 5 - Inoperable socket
Management-  Extensive  socket  surgery  with  muscle  transfer  and 
skin/dermis fat graft .
e. Implant Exposure and Extrusion:
Exposure or extrusion is described as a break in the tissue overlying the 
implant  which  in  severe  cases  may  lead  to  extrusion  of  the  implant.  Poor 
surgical technique, excessively large implant size, and infection may contribute 
to the occurrence of implant exposure. Integrated implants have been advocated 
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to decrease implant migration, improve motility, and decrease exposure.32 The 
vast majority of conjunctival exposures occur along the suture closure line.  For 
exposures  of  less  than  3  mm,  observation  may  suffice;  however,  in  larger 
exposures(more  than  10  mm),  the  use  of  free  autogenous  tissue  grafts  is 
recommended.50 Wrapping of the orbital implant, especially autologous tissue, 
and a multilayer closure reduce the possibility of implant exposure. 
f. Implant migration
This is a change in the position of the implant following placement. The 
Frost-Lange technique which involves imbrication of the recti muscles on the 
implant is associated  with higher incidence of implant migration. Sutring of the 
recti muscles independently to the implant reduces the risk.68 
g. Wound Dehiscence:
Conjunctival  wound  Dehiscence  can  be  managed  by  conservative 
therapies,  such  as  topical  antibiotics,  conjunctival  edge  freshening,  high 
posterior vaulting of the prosthesis, and scleral patch grafting.69
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PROSTHESIS
Making of the prosthesis 
1. Evaluate the socket with the help of torch light.  Ascertain the socket 
depth,    implants  if  any,  and  choose  a  suitable  impression  tray  that 
matches the socket.
2. Fit the impression tray and check for the cosmetic appearance in the area 
of the eye and orbital area and ensure about the patient’s comfort.
3. Fix the  impression tray into the socket  and pour alginate  paste using 
syringe.  Allow it  to  dry  for  3  minutes  and remove the  tray  with  the 
impression material. Using this impression tray, a wax model is made. 
Fit  the  wax  model  into  the  patient’s  socket.  Observe  the  overall 
appearance of the socket. Then the wax model is taken out and carved to 
correct the upper lid, lower lid closure by adding or carving the wax. 
4. Once the wax model is ready then make a stone mould which will be 
used for making the acrylic eye with corneal button. . For making the 
acrylic  eye,  high  grade  polymethylmethacrylate  (PMMA)  powder  is 
used. 
5. Hand painting is done on the acrylic eye by seeing the other eye which 
will look very natural. After painting, a clear coat is given and polished. 
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REVIEW OF LITERATURE
 1.  Current  trends  in  managing  the  anophthalmic  socket  after 
primary enucleation and evisceration. Su GW, Yen MT. et al. Ophthal Plast 
Reconstr Surg. 2004 Jul;20(4):274-80. 
The active membership of the American Society of Ophthalmic Plastic 
and  Reconstructive  Surgery  (ASOPRS)  was  surveyed  regarding  primary 
enucleations and eviscerations performed between January and December 2002. 
Survey questions included practice demographics, orbital implant use, wrapping 
materials,  placement  of  a  motility  peg,  reasons  for  implant  choice,  and 
complications  encountered.  A  total  of  2,779  primary  orbital  implants  were 
reported,  comprising  1,919  (69.1%)  enucleations  and  860  (30.9%) 
eviscerations.  The  high-density  porous  polyethylene  implant  was  used  most 
frequently  for  enucleations  (42.7%),  followed  by  coralline  hydroxyapatite 
(27.3%)  and  nonporous  alloplastic  implants  (19.9%).  For  eviscerations,  the 
high-density porous polyethylene implant was the most commonly used implant 
(42.3%),  followed  by  hydroxyapatite  (25.9%)  and  nonporous  alloplastic 
implants (25.7%). The top 3 reasons for implant choice were outcome (69.3%), 
cost (43.6%), and experience (39.5%). Most implants were either not wrapped 
(59.8%) or were wrapped in donor sclera (25.2%) or polyglactin mesh (7.2%). 
Pegs  were  used  in  8.1%  of  all  implants  reported.  The  most  frequent 
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complications encountered for unpegged implants were exposure (3.2%) and 
infection  (0.4%).  For  pegged  implants,  the  most  common  complications 
reported were pyogenic granuloma (13.7%),  exposure (5.7%),  and discharge 
(5.7%). They concluded that in managing the anophthalmic socket, ASOPRS 
survey  respondents  preferred  to  use  the  porous  polyethylene  implant  after 
primary enucleation and evisceration. Most orbital implants were not wrapped, 
and most surgeons preferred not to place a motility post or peg in the implant. 
2.  Exposure  rates  of  wrapped  and  unwrapped  orbital  implants 
following enucleation.  Li T, Shen J, Duffy MT.et al. Ophthal Plast Reconstr 
Surg. 2001 Nov;17(6):431-5. 
A retrospective study was conducted  on 117 enucleations over a period 
of  5 years . Data obtained included patient demographics, surgical indication, 
implant  type,  attending  surgeon,  surgical  technique,  and  any  reported 
complications.  The  primary  outcome  was  presence  or  absence  of  implant 
exposure at the final recorded visit.
Of  the  117  identified  cases,  29  were  eliminated  due  to  insufficient 
follow-up data. Of the 88 remaining cases, 48 patients received porous implants 
and 40 received solid  acrylic  implants.  Implant  exposure  developed in  four 
cases.  All  exposures  occurred  in  unwrapped  porous  polyethylene  implants 
(n=2) or porous polyethylene implants wrapped in absorbable material (n=2). 
All  exposures  occurred  in  patients  younger  than  18 years  of  age,  and 75% 
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occurred early after trauma-associated enucleation surgery. They observed that 
the exposure rate of porous polyethylene implants in this study (9%) was found 
to be comparable to published rates for hydroxyapatite implants. There were no 
exposures of unwrapped solid acrylic spheres. Unwrapped porous implants in 
pediatric  patients  or  following  trauma-related  enucleation  may  represent  an 
increased  risk  for  postoperative  implant  exposure.  Absorbable  wrapping  of 
porous implants may carry the same risk for exposure as no wrapping. They 
concluded that porous implants wrapped in durable material appear to be as safe 
as solid acrylic spheres. 
3. Orbital implants in enucleation surgery: a report by the American 
Academy of Ophthalmology.  Custer PL, Kennedy RH, Woog JJ, Kaltreider 
SA, Meyer DR. Ophthalmology. 2003 Oct; 110(10):2054-61.
On the  basis  of  an  extensive  review of  literature  they  compared  the 
prosthetic and implant motility and incidence of complications associated with 
porous and nonporous enucleation implants.
They presented that a randomized clinical trial and a longitudinal cohort 
study  detected  no  difference  in  implant  or  prosthetic  movement  between 
nonpegged hydroxyapatite porous and spherical alloplastic nonporous implants. 
Longitudinal cohort studies show that sclera-covered hydroxyapatite implants 
have  higher  exposure  rates  than  sclera-covered  silicone  implants,  and 
unwrapped  porous  polyethylene  implants  have  higher  exposure  rates  than 
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unwrapped acrylic implants. Based on one randomized clinical trial,spherical 
alloplastic  nonporous  and  nonpegged  porous  enucleation  implants  provide 
similar implant and prosthetic motility when they are implanted using similar 
surgical techniques. Coupling the prosthesis to a porous implant with a motility 
peg appears to improve prosthetic motility, but there are few available data in 
the literature that document the degree of the improvement. They concluded 
that  additional  research  is  needed  to  document  the  long-term  incidence  of 
complications related to porous enucleation implants  and associated surgical 
techniques. 
4. Functional and cosmetic relevance of primary orbital implants.
Kohlhaas  M,  Schulz  D.  Klin  Monatsbl  Augenheilkd.  2003  Jun; 
220(6):418-22.
A  prospective  study  was  conducted  on  20  patients  without  and  32 
patients with orbital implants over 6 to 14 years after enucleation. Maximum 
prosthesis motility in 4 directions, width of the palpebral fissure and vertical 
difference of the eye axis were measured using Kestenbaum glasses. The apex 
of  the  prosthesis  was  measured  with  a  Hertel  exophthalmometer.  The  post-
enucleation-syndrome was  assessed  by a  4  point  scale  by  the  investigators. 
They observed that   post-enucleation-syndromes are significantly (p < 0.01) 
less  pronounced in patients  with orbital  implants,  also prosthesis  motility  is 
significantly  (p  <  0.05)  larger.  The  width  of  the  palpebral  fissure  and  the 
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vertical difference of the eye axis is not significantly (p > 0.05) altered.  They 
concluded  that  primary  orbital  implants  allow  for  prevention  of  a  post-
enucleation-syndrome and a better functional and cosmetic outcome.
5. A simple algorithm for selection of implant size for enucleation 
and evisceration: a prospective study. Kaltreider SA, Lucarelli MJ.et al.
Ophthal Plast Reconstr Surg. 2002 Sep;18(5):336-41.
This prospective study tested a simple formula for selecting an implant 
size  for  patients  undergoing  enucleation,  evisceration,  and  secondary 
implantation. The formula axial length-2 mm=implant diameter (subtract 1 mm 
from implant diameter for evisceration and for hyperopia) was tested by the 
outcome measures, superior sulcus  deformity, enophthalmos, and volume of 
the prosthesis.   Fifty-four patients  undergoing primary or secondary implant 
surgery after enucleation or evisceration received implants based on the above 
formula.  The  volume  of  the  eye,  volume  of  the  implant,  volume  of  the 
prosthesis,  and the total percent volume replacement were recorded for each 
patient.  Outcome  measures  considered   clinically  acceptable  were  <2  mm 
enophthalmos and less than grade 1 superior sulcus deformity, which is defined 
as  barely  perceptible  deepening  of  the  medial  superior  sulcus.  The  average 
volume  replacement  was  101%;  average  prosthetic  volume  was  2.1  mL; 
average grade of superior sulcus deformity was 0.6; and average enophthalmos 
was 1.2 mm. They concluded that this formula allows 100% replacement of the 
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volume removed, leaves space for a prosthesis 1.5 to 2.5 mL, and eliminates 
clinically unacceptable superior sulcus deformity and enophthalmos in 85% of 
patients. Patients with a history of infection, radiation, buphthalmos, or large 
orbital  fractures  (15%)  had  residual  superior  sulcus  deformity  greater  than 
grade 1 and enophthalmos > or =2 mm despite 100% volume replacement.  
6.  Comparison  of  artificial  eye  amplitudes  with  acrylic  and 
hydroxyapatite  spherical enucleation implants. Colen TP, Paridaens DA, et 
al Ophthalmology. 2000 Oct;107(10):1889-94.
This was a randomized, controlled trial aimed at comparing artificial eye 
amplitudes in patients  who randomly received either a hydroxyapatite  or an 
acrylic,  scleral-covered  spherical  implant  after  enucleation.  Eligible  patients 
randomly  received  a  hydroxyapatite  or  an  acrylic,scleral-covered  spherical 
orbital implant. Fourteen patients were fitted with a hydroxyapatite implant, and 
16 were fitted with an acrylic implant. They measured horizontal and vertical 
saccadic  amplitudes  of  both  the  artificial  eye  and  the  healthy  eye  using 
magnetic search coils technique. Saccadic amplitudes of the artificial eye were 
compared with the healthy eye of the patient. The amplitudes of the healthy 
eyes  were  compared  with  saccadic  amplitudes  of  control  participants.  The 
interval from surgery to measurements was at least 3 months in all  patients. 
Saccadic gain (artificial eye and eye amplitude divided by target amplitude) and 
saccadic symmetry (artificial eye amplitude divided by healthy eye amplitude) 
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were calculated. The main outcome measures were saccadic gain and saccadic 
symmetry. They observed that   the gain in the healthy eyes of the patients was 
comparable with the gain of the control eyes. Saccadic symmetry was 1.0 in 
control participants. In patients, it was 0.334 in horizontal saccades and 0.577 in 
vertical  saccades.  However,  saccadic  symmetry  did  not  differ  significantly 
between  the  acrylic  group  and  the  hydroxyapatite  group  (P:  >  0.1  for  any 
saccadic direction). They concluded that when no motility peg is placed, acrylic 
and hydroxyapatite spherical implants yield comparable saccadic amplitudes of 
the artificial eye and artificial eye amplitudes were markedly more restricted 
horizontally than vertically. 
6. Extrusion rate of silicone spherical anophthalmic socket implants. 
Nunery WR, Cepela MA,et al. Ophthal Plast Reconstr Surg.1993 Jun;9(2):90-5.
They  analysed  that  the  Frost-Lange   technique  which  incorporates 
imbrication  of  recti  muscles  over  an  18  mm  spherical  implant,  and  purse 
stringing  of  conjunctiva  and  Tenon's  fascia  in  a  single  layered  closure  and 
reported that  the technique has led to  extrusion rates as high as 11.3% and 
superotemporal implant migration and poor prosthetic motility. They modified 
the technique which includes suturing recti muscles independently to a 20 mm 
spherical  implant  reinforced with  autogenous  fascia  or  preserved sclera  and 
then closing Tenon's fascia and conjunctiva independently as separate layers. 
They observed that the extrusion rate during a 10 year study period was 0.84% 
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(1 of 119).  There  were no cases of  implant migration, painful socket,  and 
prosthetic motility was good. They recommend their technique modification to 
replace the traditional Frost-Lange technique.
7. Prosthesis motility with and without intraorbital implants in the 
anophthalmic  socket. Smit  TJ,  Koornneef  L et  al.  Br  J  Ophthalmol.  1991 
Nov;75(11):667-70. 
Ocular prosthesis motility was measured and compared in 15 patients 
with a primary baseball implant after enucleation of an eye, in 11 patients with 
a secondary baseball implant, in 12 patients with an Allen implant, and in 11 
patients  without  any  intraorbital  implant.  In  all  patients  a  noticeable  lag  of 
movement of the prosthetic eye was measured: in the extreme directions of gaze 
the  excursions  of  the  prosthesis  were  far  less  in  comparison  with  the 
contralateral normal eye. For normal eye movement round the primary position 
of  gaze,  however,  the  prosthesis  motility  in  the  primary  baseball  and Allen 
implant  group  appeared  to  be  sufficient  to  give  a  lifelike  appearance.  The 
average  motility  of  the  prostheses  in  these  two  groups  did  not  differ.  The 
motility in the secondary baseball group and in the group without an implant 
was  evidently  worse.  In  the  last  group  the  prosthesis  motility  was  most 
impaired. They concluded that the insertion of an implant, even when inserted 
some time after the enucleation (a secondary implant), improves the motility of 
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the prosthesis markedly. They  recommend the primary baseball implant as the 
correction of choice after enucleation.
8.  Enucleation  with  unwrapped  porous  and  nonporous  orbital 
implants: a 15-year experience.Trichopoulos N, Augsburger JJ et al. Ophthal 
Plast Reconstr Surg. 2005 Sep;21(5):331-6.
This was a retrospective analysis of a series of 258 patients who received 
either an unwrapped nonporous spherical implant   (n = 68) or an unwrapped 
porous spherical implant (n = 190) to find out the  actuarial rates of migration 
of the implant and implant exposure.  Median follow-up duration in this  study 
was 37.6 months. Implant exposure occurred in 1 of the 68 nonporous implant 
cases (1.5%) and in 4 of the 190 porous implant cases (2.1%). This difference is 
not statistically significant (P = 0.85). In contrast, clinically significant implant 
migration occurred substantially more frequently in the patients who received a 
nonporous implant. The cumulative actuarial probability of implant migration at 
60 months was 15.5% for the nonporous implants versus 0.7% for the porous 
implants.  This  difference  was  statistically  significant  (P  =  0.0003).  They 
concluded that   orbital  implant migration occurred in  a significantly greater 
proportion of patients  who received a nonporous implant than in those who 
received a porous implant. Implant exposure occurred at a low rate that was not 
significantly different in the two subgroups. 
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9. Tarsal strip procedure for correction of eyelid laxity and canthal 
Malposition in the anophthalmic socket. Anderson RL et al. Ophthalmology. 
1981 Sep;88(9):895-903. 
They studied that surgically anophthalmic sockets commonly have laxity 
of  the  lower  eyelid,  inferior  displacement  of  the  lower  eyelid  and  lateral 
canthus, shallowing of the inferior fornix, and a deep superior sulcus and these 
deformities  result  in  difficulty  in  prosthesis  retention,  pooling  of  tears  and 
mucus,  epiphora  and  lower  eyelid  irritation,  and  poor  cosmesis  with  an 
appearance of facial asymmetry. The  main anatomic deformity is a marked 
laxity and elongation of the lateral canthal tendon. The tarsal strip procedure is 
ideal  for  correcting or  improving these  deformities  simultaneously  with one 
simple procedure.  They observed good results  in 26 patients  with surgically 
anophthalmic  sockets  in  which  the  above  procedure  was  utilized.  They 
recommended  the tarsal strip procedure not only to correct these conditions in 
anophthalmic sockets but in almost any condition where  laxity of the eyelids or 
canthal malposition requires surgical correction.
10. Complications of orbital implants: a review of 542 patients who 
have undergone orbital implantation and 275 subsequent PEG placements. 
Shoamanesh A, Pang NK, Oestreicher JH. Orbit. 2007 Sep;26(3):173-82. 
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This was a retrospective chart  review of 542 patients who underwent 
eviscerations, enucleations and secondary procedures by one surgeon to study 
the  complications  associated with three  commonly  used orbital  implants,  as 
well  associated anophthalmic socket issues..  Approximately 60% of patients 
experienced complications prior to implant drilling, with discharge being the 
most  prevalent  (15.9%).  Secondary  procedures  were  associated  with 
significantly  greater  complication  rates  prior  to  implant  drilling.  Silicone 
implants  had significantly less pre-pegging pyogenic granuloma (P = 0.011) 
and hypo-ophthalmos (P = 0.042) than the other implant types. Seven implants 
had to be removed due to exposure. Implant drilling and peg placement were 
performed in 275 patients. Implant drilling complications were experienced by 
67.4% of pegged patients, with a change in discharge from prior to pegging 
(27.2%) being the most prevalent. Plastic peg systems had a significantly higher 
incidence  of  complications  than  titanium systems.  They  concluded  that  the 
majority  of  orbital  implantations  involve  complications,  these  being  largely 
minor  ones  which  resolve  spontaneously  or  are  easily  treated.  Secondary 
implant  procedures  involve  a  higher  likelihood  of  complications.  Silicone 
implants have the smallest amount of complications. Should patients decide to 
undergo pegging,  evidence sides  strongly for  the  use of  a titanium peg and 
sleeve  system  over  the  other  peg  types.  Implant  removal  is  a  rare  event; 
occurring in 1.3% (n = 7) of the study population. 
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11:  Comparison  between  motility  of  biointegratable  and  silicone 
orbital  implants.   González-Candial  M,  Umaña  MA,  Galvez  C,  Medel  R, 
Ayala E.  Am J Ophthalmol. 2007 Apr;143(4):711-2. 
      A retrospective comparative study was conducted to determine any 
difference  in  motility  between  biointegratable  orbital  implants  and  silicone 
orbital  implants  in  patients  undergoing  ocular  evisceration.  They  compared 
motility measuring the excursion of a mark on the conjunctiva at the center of 
the implant in eviscerated patients with silicone implants and biointegratable 
implants  after  same  evisceration  technique.  Silicone  implants  had  0.5-mm 
increased  movement  in  inferior  and  medial  duction  compared  with 
biointegratable  implants.  The  later  had  0.1  mm  of  increased  movement 
compared with silicone implants in lateral gaze. The greatest difference was in 
superior  gaze,  in  which  silicone  implants  had  1.5 mm more  excursion  than 
biointegratable implants. No significant difference was observed in horizontal 
and vertical movements between both groups. They concluded that, there does 
not seem to be any advantage,  in terms of motility,  in using biointegratable 
implants if "pegging" is not planned. Further studies are required.
12.Synthetic  hydroxyapatite-based  integrated  orbital  implants:  A 
human pilot trial: Kundu B, Sinha MK, Mitra S, Basu D.. Indian J Ophthalmol 
2005;53:235-241
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The study evaluated the efficacy of two different models of synthetic 
HAp with 75% porosity and pore sizes ranging from 100 to 300 mm. in 25 
patients. The postoperative performances of these implants were evaluated in 
respect  to  the  degree  of  volume  replacement  (implant  +  prosthesis), 
presence/absence of lagophthalmos and lower eye-lid laxity, status of socket 
and fornices. Magnetic resonance imaging assessed the stability of the implants 
within  the  socket  and  progressive  fibro-vascularisation  within  the  porous 
scaffold as a function of time. Finally, motility of the implants as well as the 
prostheses (horizontal movements by Lister Perimeter) and subjective cosmetic 
results  (qualitative)  were  also  evaluated.  During  the  2.5  years  of  follow-up 
study,  no  significant  postoperative  complications  were  noticed.  One  case, 
showed an anterior implant exposure of 3-4 mm, and was managed with donor 
scleral patch graft and one case of conjunctival thinning was corrected by re-
suturing the conjunctival dehiscence. Fourteen of the 25 patients had a very 
good movement of the prostheses (> 20° horizontal movement) and the other 11 
patients had a fair motility (10 - 20°). The degree of volume replacement (with 
prosthesis) was found to be very good in 21 patients and fair in other 4 patients. 
All patients reported cosmetic satisfaction. They concluded that  synthetic HAp-
based  integrated  orbital  implants  with  this  modified  design  were  found 
clinically safe and cosmetically acceptable. 
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AIMS AND OBJECTIVES
1. To  study the demography of patients  receiving orbital implants 
following enucleation and evisceration.
2.  To evaluate the efficacy  of silicone ball orbital implant  in primary 
enucleation and evisceration .
3. To study the  complications related to the use of silicone orbital 
implants.  
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MATERIALS AND METHODS
            A prospective, descriptive, randomized interventional study on the 
outcome  and  complications  of  enucleation  and  evisceration  surgeries  using 
silicone  orbital  implants   was  conducted  in  the  Department  of  Orbit, 
Oculoplasty and Ocular oncology, Aravind eye  Hospital, Madurai.
            The  study was conducted from March 2006 to August  2007. The 
patients who underwent any of the above mentioned surgical procedures during 
the specified were enrolled based  on the inclusion and exclusion criteria. 
Inclusion criteria:
1. Patients having any of the following symptoms : 
    1.1 Penetrating  trauma causing blindness
    1.2. A blind eye with severe deformation of the globe
    1.3. Painful blind eye due to non malignant disease
    1.4. Pthisis bulbi
2.  Patients  who  were  willing  to  participate  in  the  study  and  ensured  good 
compliance. 
Exclusion  criteria :
 Blind  or disfigured eye secondary to :
1. Complex orbital trauma
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2. Primary malignant ocular tumors
3. Secondary orbital metastatic tumors.
4. Systemic malignancy
5. Contracted socket -  grade 2 or more.   
 
Clinical evaluation of the cases: 
All the patients involved in the study were evaluated in detail prior to the 
surgery. 
The patients’  particulars like  name , age, sex, address, economic status 
were documented.
Pre- operative evaluation included thorough history taking pertaining to 
ocular  and general systemic pathology and trauma which may influence the 
outcome  of the surgery A detailed history was taken regarding the cause of 
blindness, the presence of pain,and  the duration of the symptoms.. The patients 
were also enquired about  h/o orbital trauma, h/o neoplasm, h/o medical therapy 
for  neoplasm,  h/o  radiotherapy  which  could  influence  the  outcome  of  the 
surgery. Both  the eyes of the patient were examined and the indication for the 
surgery was established. The socket of the affected eye was examined to rule 
out  lid  malpositions,  forniceal  abnormalities  and  contracted  sockets   which 
could again influence the outcome of the study. The axial length of the normal 
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eye was  measured  to have a rough estimate of the size of the implant that 
could be placed.   
Preanaesthetic medication and anaesthetist ‘s opinion was obtained in all 
cases. The investigations included hemoglobin %, bleeding time , clotting time, 
tests to rule out diabetes, blood pressure recording, renal parameters like blood 
urea,  serum  creatinine,  serum  electrolytes,  and  electrocardiography.  All  the 
surgeries  were  performed  under  general  anaesthesia.  The   choice  of  the 
anaesthetic  drug  depended on the systemic status of the patient.
The surgical technique: 
Enucleation with silicone implant:
Under  general  anaesthesia  ,  the  patient  is  prepared  and  draped  for 
surgery. After ensuring the correct eye to be operated, the eye is exposed to the 
operating sterile field.
The eyelids are retracted with a speculum. A 360 degree peritomy is 
made at the limbus to preserve as much conjunctiva as possible and to permit 
adequate  fornices  in  the  anophthalmic  socket.  Each  rectus  muscle  is  then 
isolated by passing a muscle hook behind it  from either side. The muscle is 
ligated with an absorbable suture like, 6-0 vicryl  which is passed through the 
muscle in a serpentine fashion, approximately 2 mm behind its insertion on the 
globe.  The suture is locked on each side of the muscle.  The muscle is  then 
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severed between the suture and the globe. The ends of the suture can then be 
used  to  retract  the  muscle  away from the  globe.  Similarly  the  superior  and 
inferior oblique muscles are isolated.
A smooth  instrument  e.g.  muscle  hook  is  passed  along  the  globe  to 
ensure that Tenon’s capsule is completely removed from the globe in all areas 
upto the optic nerve. The eyeball is luxated out  by speculum / or clamp and 
enucleation scissors , the optic nerve is cut as far as possible and the globe is 
removed.   Hemostasis  is  achieved by pressing a piece of  gauze to  promote 
vasoconstriction and by using bipolar cautery to the bleeding vessels so as to 
prevent or control bleeding. In case of excess bleeding , bone wax can be used. 
The Tenon’s capsule is separated from the conjunctiva using blunt dissection.
The implant which is to be used is wrapped with donor sclera, before 
starting the enucleation. This wrapped implant is placed  is placed within the 
socket.  The orbital  fat  should be seen through this  posterior  opening in  the 
Tenon’s capsule. The implant is placed through this opening  into the orbital fat 
(i.e..  placing  the  implant  posterior  to  the  posterior  Tenon’s  capsule).  The 
muscles  are  then  attached  in  the  following  manner.  The  medial  rectus  is 
attached to the medial aspect of the sclera wrapped implant .  Similarly, in a 
spiral pattern  the lateral rectus is attached to the lateral aspect, the superior 
rectus is attached to the upper aspect and the inferior rectus to the lower aspect 
of the implant .
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The anterior aspect of the tenon’s capsule is closed with interrupted 6-0 
vicryl sutures. The conjunctiva is closed with running continuous vicryl sutures.
An antibiotic ointment is applied to the socket. A transparent conformer 
with several small 2 mm sized holes is placed in the socket. The size of the 
conformer  should  permit  the  eye  to  be  closed  without  any  tension  on  the 
fornices. The  eye is closed and patched firmly with 2- 3 eye pads.
Evisceration  with silicone implant: 
Under  general  anaesthesia,  the  patient  is  prepared  and  draped  for 
surgery. After ensuring the correct eye to be operated, the eye is exposed to the 
operating sterile field. The eyelids are retracted with a speculum. A 360 degree 
peritomy is made at the limbus to preserve as much conjunctiva as possible and 
to permit adequate fornices in the anophthalmic socket. Tenon’s capsule and the 
conjunctiva  are  undermined  posteriorly  towards  the  insertion  of  the  rectus 
muscles. The anterior chamber is entered at the 12 o ‘clock position and the 
cornea is completely excised with scissors. An  evisceration spoon is used and 
the contents of the globe are delivered in toto by scooping the specimen out 
from behind with the evisceration spoon.  Occasionally profuse bleeding from 
the central retinal  artery and vortex vessels occurs, which can be controlled 
with direct pressure with gauze packing ,application of minimum direct cautery 
to the bleeding points. Once the field is bloodless the remaining shreds of uveal 
pigment are removed with forceps and curette or a moistened gauze. The scleral 
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cavity is irrigated with povidone iodine  solution and the cavity is re-inspected 
meticulously  to  ensure  that  all  pigmented  tissue  is  removed.  Small   linear 
relaxing incisions  are made  at the 3  and 9 o’ clock positions with care taken to 
avoid  the  insertion  of  the  rectus  muscles.  These  relaxing cuts   can  also  be 
placed at the oblique quadrants, alternatively.  The intraocular implant of the 
desired size is inserted  and the scleral wound is approximated or can be closed 
by overlapping  the  wound edges in a horizontal line, using multiple mattress 
sutures  of  6-0  vicryl  sutures.  Tenon’s  capsule  is  re-approximated  with 
interrupted 6-0 vicryl sutures.  The conjunctiva is  closed with running vicryl 
sutures.
An antibiotic ointment is applied to the socket. A transparent conformer 
with several small 2 mm sized holes is placed in the socket. The size of the 
conformer  should  permit  the  eye  to  be  closed  without  any  tension  on  the 
fornices. The eye is closed and patched firmly with 2- 3 eye pads.
Post operative evaluation:
The patient’s eye was examined on the first post operative day to detect 
complications like hemorrhage, wound dehiscence, exposure  of the implant. 
Antibiotic eye ointment was  applied  and analgesics were given and the patient 
was asked to continue them for 2 weeks.  The patient was reexamined at the end 
of 15 days, 30 days ,  and 3 months. The patients were advised to fit custom 
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made prosthesis 4 to 6 weeks post operatively after ensuring adequate  wound 
healing by the doctor.
The outcome and the cosmesis:
        The post operative performance of the eye was analysed after fitting the 
prosthesis on the basis of:
1. The  volume replacement   –
The degree of volume replacement (with implant and prosthesis)  was 
assessed quantitatively by proptometry  , while the qualitative assessment was 
performed  by  observing  the  superior  sulcus  deformity.   Using  a  Luedde’s 
exophthalmometer the distance between the  lateral orbital rim and the apex of 
the cornea (in the normal eye) was measured.  The distance between the  lateral 
orbital   rim and  and the tip of the prosthesis was measured.  The diference 
between the the two measurements was calculated. A difference of 2 mm or less 
was considered  as good volume replacement. The presence of lagophthalmos 
or ptosis was also documented.
      2. The ocular motility
        The ocular motility was based on Kestenbaum’s limbal excursion 
method. The readings were documented as:- 
         a) no movements :       -4   (poor)
         b)25 % movements : -3   (fair)
         c)50 %  movements :   -2   (good)
         d)75 % or more : -1    (excellent)
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Subjective evaluation:
         The patients’ complaints such as pain , pain related to ocular movements,  
irritation,  and  discharge   were  also  considered.  Last  but  not  the  least  ,  the 
patient was enquired whether he or she was happy and satisfied by the outcome 
of the surgical procedure. 
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RESULTS
             Based   on the exclusion and inclusion criteria, 65 cases were taken up 
for the study. 
Demographic study:
1. Age distribution of cases
Age
Age Minimum Maximum Mean 
Age 5 72 29.85
Age group
Age  group   (in 
years)  
Frequenc
y 
Perce
nt 
<20 11 16.9
20-40 41 63.1
40-60 11 16.9
>60 2 3.1
Total 65 100
Most of the patients in the study belonged to the age group 20 to 40 
years. The minimum age was 5 years and the maximum age was 72 years. The 
mean age was 29.85 years with a standard deviation of 13.766. 
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2. The gender 
Age Group and Gender Cross tabulation 
Age group Gender TotalMale Female 
<20 6 8 11
20-40 29 15 41
40-60 6 5 11
>60 1 1 2
Total 42 23 65
Of the 65 patients, 42 were males (64.6%) and 23 were females (35.4%).
3. The laterality 
Laterality Frequency Percent
Right Eye 29 44.6
Left Eye 36 55.4
Total 65 100.0
        Of the 65 patients, 29 of them had involvement of the right eye and 36 of  
them had involvement of the left eye. 
4. The indications for surgery
Indications for surgery Frequency Percent
Penetrating Trauma Causing Blindness 4 6.2
Severe Deformation of the globe 31 47.7
Painful blind eye due to nonmalignant cause 11 16.9
Pthisis Bulbi 19 29.2
Total 65 100.0
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47.7% of the patients underwent surgery due to severe deformation of 
the globe. 29.2% of them had pthisis bulbi. 16.9% of the patients suffered due 
to a painful blind eye   due to nonmalignant disease (like endophthalmitis / 
panohthalmitis  induced blindness,  secondary glaucoma, etc).   The remaining 
6.2 % underwent surgery for penetrating trauma.
5. The type of surgery  
Type of surgery  Frequency Percent
Enucleation with implant 58 89.2
Evisceration with implant 7 10.8
Total 65 100.0
89.2% of the patients in the study underwent  enucleation with silicone 
implant and 10.8% underwent  evisceration with silicone implant. 6 out of the 7 
patients  underwent  evisceration  because  they  had severe  deformation  of  the 
globe.   
6.  The size of the implant 
Implant size Frequency Percent
14mm 7 10.8
16 mm 48 73.8
18 mm 10 15.4
Total 65 100.0
A 16 mm implant  was used in  most of  the cases  (48 cases).   In  the 
remaining 17 patients, 10 patients had a 18 mm implant and 7 of them had a 14 
mm implant.  
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7. Post operative complications   
Complications Frequency Percent
1. Conjunctival dehiscence 3 4.6
2. Conjunctival granuloma 1 1.5
3. Socket contracture grade 1 
and symblepharon 
1 1.5
4. Retention cyst 1 1.5
5. Implant exposure 1 1.5
6. Implant extrusion 3 4.6
Of  the  65  patients  who  underwent  the  surgery,  10  of  them  had 
complications.  3 patients had conjunctival dehiscence.  One patient developed 
a conjunctival granuloma and another a retention cyst. 3 patients had implant 
extrusion. There was one case of implant exposure. The above complications 
were managed as described below.  
Complications Additional surgery
1. Conjunctival dehiscence Conjunctival resuturing
2. Conjunctival granuloma Granuloma excision
3.  Socket  contracture  grade  1 
and symblepharon
Fornix  deepening  suture  and 
symblepharon release
4.Retention cyst Needling 
5.Implant  exposure Scleral patch graft
6.Implant extrusion
          Case 1 Repeat  surgery  using  a  smaller 
implant and a scleral patch graft
          Case 2 Socket  debridement   and  broad 
spectrum antibiotics 
          Case 3 Dermis fat graft 
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8. Fitting of the prosthesis  
Prosthesis fitting Frequency Percent
Prosthesis 59 90.8
No prosthesis 6 9.2
    - due to complication    4 6.1
    - due to lack of follow up 2 3.1
   
59 patients were fitted with either custom made or stock prosthesis. Of 
the remaining 6 patients, 4 of them were not fitted with prosthesis because of 
complications and 2 of them did not come for follow up.  
 9. Type of prosthesis  
Prosthesis Frequency Percent
Custom fit 41 69.5
Stock fit 18 30.5
Of the 59 patients, 41 patients were fitted with custom made prosthesis. 
The others preferred to use stock prosthesis.
10. Volume replacement 
Volume Replacement Frequency Percent
No difference 43 73
<2 mm 11 18.6
>2mm 5 8.4
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Of the 59 patients,  the volume replacement was poor in 5 cases.  The 
remaining 54 patients (91.6%) either had no volume deficit or had less than or 
equal to 2 mm difference which was considered as good cosmesis. 
11. Ocular motility     
Ocular Motility     Frequency Percent
50% movements 37 62.7
25 % movements 6 10.2
 No movement 16 27.1
37 patients had nearly 50% ocular motility.  Of the remaining patients, 6 
of them had atleast 25 % motility while the others had no ocular movement.     
12. Subjective evaluation of the procedure
12.1 Discomfort
Discomfort Frequency Percent
Pain Present 5 7.7
Absent 54 83.1
Discharge 
Present 2 3.1
Absent 57 87.7
Total 5 7.7
 
Of the 59 patients who were fitted with prosthesis, 5 of them experienced 
discomfort either in the form of pain or discharge. The rest were comfortable.
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12.2 Cosmesis.  
Cosmesis Frequency Percent
Satisfied 43 72.9
Not satisfied 16 27.1
43 out of the 59 patients were happy with the outcome of the procedure. 
The others included patients who needed a secondary procedure to correct the 
lid laxity and those who preferred to use a stock prosthesis. 
12.3 Lower eyelid laxity 
             18 out of the 59 patients had lower lid laxity and the rest had a normal  
lower lid anatomy.  
12.4. Additional surgery after prosthesis fitting 
For Lid laxity Frequency Percent
Lateral tarsal strip 6 10.1
Lateral tarsorrhaphy 2 3.3
Lateral tarsal strip with tarsoraphy 2 3.3
Total 10 16.9
After  fitting  the  prosthesis  there  were  10  patients  who  required  and 
desired an additional surgery for their lower lid laxity. 
Lower eyelid laxity Frequency Percent
Present 18 30.5
Absent 41 69.5
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DISCUSSION
The management of an anophthalmic socket is a challenge to the treating 
ophthalmologist.  The restoration of  both comfort  and cosmesis  is  extremely 
important  to  the  patient  who  is  already  suffering  due  to  the  psychological 
trauma following the loss of an eye. The role of the ophthalmologist begins 
from discussing the  preparation  for  surgery  and the  patient’s  post  operative 
appearance, upto providing emotional assistance in returning the patient to a 
productive  life.  There  are  varied  options  of  treating  these  patients  and  the 
current  trend is  the  usage of  orbital  implants  during  primary  enucleation or 
evisceration. The choice of implant depended on the cost the outcome and the 
experience of the surgeon. 
The current study was carried out over a period of 18 months on 65 
patients to determine the efficacy of silicone ball orbital implants. This case 
series have shown favourable results of the silicone ball implant. Analyzing the 
demographic details in our study, it is seen that most of our patients (62.1%) 
were between 20 to 40 years of age.  The male patients were predominant group 
in the study. The above parameters could vaguely suggest the higher incidence 
of ocular trauma in the males and the interest in retaining good cosmesis in the 
occupationally and socially active group of our society.      
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Regarding the performance of these implants, the volume replacement 
was 91.6% (54 out of the 59 patients), the  remaining had inadequate volume 
either because of  the use of a smaller implant  or the patient preferred to use a 
stock fit  prosthesis.  The custom fit  prosthesis has the advantage of adding a 
little more volume to the orbit thus achieving better volume replacement. The 
empirical formula described by Kaltreider70  can be used only as a guide to the 
size of the implant. It is calculated only for the globe’s axial length and does not 
include the retrobulbar volume (which includes the orbital fat and connective 
tissue). It   is well known that orbital fat atrophy occurs in long standing cases 
of phthisis bulbi (19 cases).
The  ocular  motility  was  good  in  62.7  % of  the  patients,  and fair  in 
10.2%. The rest had unsatisfactory motility  due to  an overweight custom fit 
prosthesis,  a  poorly  fit  stock  prosthesis,  a  smaller  implant,  and  different 
surgeons although the same technique. The prosthetic motility is determined by 
a variety of  factors.  The size,  shape and weight of  the prosthesis  affect  the 
ultimate  movement  of  the  prosthesis.  Larger,  heavier  prosthesis  generally 
demonstrate less movement. Superior augmentation of the prosthesis to correct 
ptosis  or  a  deep superior  sulcus  also limits  motility.  Although these  factors 
somewhat dependent on the spherical implant size, they are independent of the 
implant  material.  Extraocular  muscle  function  is  transmitted  via  the  scleral 
capsule of the implant to the overlying Tenon’s fascia and the conjunctiva. The 
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nonpegged  prosthesis  are  indirectly  coupled  to  the  implant  via  the  surface 
tension at the prosthetic- conjunctival interface71. In a randomized control trial 
conducted by Colen TP, Paridaens DA, et  al72,   it  was observed that  in the 
absence  of  motility  pegs,   nonporous  (acrylic)  and  porous  (hydroxyapatite) 
spherical implants yield comparable saccadic amplitudes of the artificial eye 
and artificial eye amplitudes were markedly more restricted horizontally than 
vertically. Custer et al71 in their longitudinal cohort study of 107 patients also 
found no difference in motility between hydroxyapatite and nonporous scleral 
covered implants. Coupling the prosthesis to a porous implant with a motility 
peg appears to improve prosthetic motility, but there are few available data in 
the literature that document the degree of the improvement.  Larger implants 
seem  to  provide  improved  implant  motility,  which  should  result  in  more 
dramatic prosthetic movement. But excessively large implants may increase the 
risk  of  extrusion,  make  prosthesis  fitting  difficult,  or  result  in  patient 
discomfort. Ideally, sufficient space must remain in the socket to allow fitting 
of the prosthesis with atleast 2 ml volume and approximately 4 mm central 
thickness73.  
In  our  study,  the  patients  satisfaction  was  evaluated  based  on  the 
discomfort, and the overall satisfaction of their surgical outcome. There were 
only  5  patients  who experienced discomfort  and the  majority  87.7  % were 
comfortable  in  all  the  follow ups.  Regarding the  overall  satisfaction,  nearly 
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73% were happy.  The rest (16 patients) were unsatisfied either because they 
had a cosmetic deficit like lower lid laxity, or were fitted with stock prosthesis 
due to economic problems. All the patients who desired a corrective procedure 
underwent either a lateral tarsal strip, lateral tarsorrhaphy, or both as decided by 
the  surgeon.  These  patients  were  also  happy  at  the  end  of  the  corrective 
procedure, thus increasing the overall satisfaction rate to 89.9 %. The major 
complication  encountered  in  our  study  were  exposure  and  extrusion  of  the 
implant.  There  were  3  cases  of  extrusion  (4.6%) and one  case  of  exposure 
(1.5%). All the 4 cases of extrusion and exposure were due to infection of the 
wound.  The extrusion/exposure rates in other studies were: 
S No. Authors Type  of  implant Exposure rate
1. Su GW, Yen MT. et al. Unpegged implants
Porous polyethylene
Hydroxyapatite
Nonporous 
3.2%
1.8%
1.21%
0.03%
2. Li T, Shen J, Duffy MT. et al. Porous polyethylene 9%
3. Nunery WR, Cepela MA, et al. Silicone 0.84%
4. Trichopoulos N, Augsburger JJ et al. Acrylic 
Porous polyethylene
1.5%
2.1%
5. Christmas NJ, Gordon CD, Murray TG, 
et al.
Hydoxyapatite
Acrylic
Silicone   
1.1%
2.6%
0
6. Our study Silicone 6%
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CONCLUSION
In our  study,  65  patients  who  underwent  primary  enucleation  or 
evisceration were fitted with silicone ball orbital implants during March 2006 to 
February 2007. Each of these patients were followed over a period of 6 months 
post operatively. 
1. The age distribution of patients were such that the maximum number of 
patients (69.1%) were in the age group of 20 to 40 years. 
2. Males constituted 64.5% while females constituted 34.5%. 
3. The major indication in our study patients was severe deformation of the 
globe (e.g. staphyloma) (47.7%), followed by pthisis bulbi (29.2%).
4. Most of the patients underwent primary enucleation with silicone ball 
implant (89%) while only were the rest (11%) underwent evisceration 
with silicone implant. 
5. Of  the  65  patients  who  underwent  the  surgery,  10  of  them  had 
complications. There were three cases of implant extrusion and one case 
of implant exposure. 
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6. After fitting the prosthesis, the good volume replacement was achieved 
in 91.6%, and, the ocular motility was good in 62.7% of the patients.
7. Nearly 90% of the patients were satisfied with their surgical outcome. 
         Considering the overall picture, it is evident that the use of silicone ball 
orbital implant post enucleation or evisceration is definitely beneficial to the 
patient in terms of improving his quality of life. The best implant to use remains 
a matter of controversy and surgeon preference. Implant costs, hospital budget 
restraints,  and  marketing  pressure  all  influence  which  implant  is  favored. 
Current clinical evidence is not sufficient to suggest either that porous implants 
are superior to non-porous implants, or that one material is more suited to the 
application than another. Future developments in this field require randomized 
controlled clinical trials with extensive follow-up to decide the best implant.
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